more than one disease category of interest, results for each disease were included separately. Where two studies reported results based on an overlapping cohort, we selected the most recent study and/or the study with the largest sample size. Where studies did not specify the disease type or the pathological classification was unclear, we included these results as "glomerulonephritis, disease type not specified". Titles, abstracts and full-text studies were reviewed in single, several months apart by one reviewer (AO). To ensure accuracy, a duplicate review of studies was conducted (KB).
Quality Assessment
We evaluated the methodological quality of included studies using the criteria developed by Loney et al 3 . Studies were assessed based on 3 broad areas: 1) how the population was sampled 2) how the outcome was measured and 3) how the results were interpreted. The maximum number of points that could be achieved was 8 points, and studies were deemed to be at low risk of bias if they achieved at least 6 points (Table 1 -Appendix).
Statistical and Qualitative Analysis
The percentage of live births was calculated for each relevant disease category within each study. We refrained from conducting a meta-analysis because there was substantial heterogeneity (I2>70%) and few studies reported baseline data on participants to allow us to explore the sources of heterogeneity. Therefore, we conducted a qualitative, descriptive analysis only.
Data Abstraction
Data were independently abstracted by one reviewer (AO) and reviewed by a second reviewer (KB).
Differences were reconciled by discussion or consultation with a third reviewer (MH). The following data Table 2 -Appendix where available. 
